Magsoothium Cbd Body

Description

Magsoothium Body Spray is a homeopathic pain reliever formulated with magnesium and arnica. This product is designed to help relieve minor aches and pains. It is presented in a dosage form of a spray, with net contents of 4 fluid ounces (118.3 mL). Magsoothium Body Spray is manufactured in the United States.

Uses and Indications

This drug is indicated for the relief of minor aches and pains. It is a homeopathic pain reliever formulated with magnesium and arnica.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children over the age of 2 years are advised to apply the product generously to the affected area, using gentle rubbing, 2 to 3 times daily or as needed. For children under the age of 2 years, it is recommended to consult a physician prior to use.

The product is intended for topical application only. Care should be taken to ensure that the application is performed gently to avoid irritation of the skin.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed. It is imperative that the area being treated is not bandaged or covered, and the application of ice or heating pads in conjunction with this product is contraindicated. The use of this product with any medical device or other devices is prohibited, as is the combination with any other topical treatments.

Healthcare professionals should advise patients to avoid contact with the eyes and mucous membranes, and to refrain from applying the product to wounds or damaged skin. Pregnant or breastfeeding individuals should consult a healthcare professional prior to use.

General precautions include keeping the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

No laboratory tests are specified for monitoring during the use of this product.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should be applied strictly as directed. It is crucial not to bandage or cover the area being treated, nor should ice or heating pads be used in conjunction with this product.

Additionally, patients are advised against using this product with any medical device or other topical treatments, as such combinations may lead to adverse effects. Care should be taken to avoid contact with the eyes or mucous membranes, and the product should not be applied to wounds or damaged skin.

For pregnant or breastfeeding individuals, it is recommended to consult a health professional prior to use to ensure safety for both the patient and the child. Adhering to these guidelines is essential to minimize the risk of adverse reactions.

Drug Interactions

The use of this medication is contraindicated with any medical device or other device, as well as with any other topical treatment. Co-administration may lead to adverse effects or diminished therapeutic efficacy.

There are no specific laboratory test interactions reported for this medication. Therefore, routine monitoring of laboratory tests is not required in conjunction with its use.

Packaging & NDC

Below are the non-prescription pack sizes of Magsoothium Cbd Body (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center.

For dosing, the product is indicated for use in adults and children over the age of 2 years. The recommended application is to apply generously with gentle rubbing to the affected area 2-3 times daily or as needed. For children less than 2 years of age, consultation with a doctor is advised prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients should apply the medication generously with gentle rubbing to the affected area 2-3 times daily or as needed. Clinicians should advise patients to keep the product out of reach of children and to seek medical help or contact a Poison Control Center immediately in the event of accidental ingestion.

Patients are instructed to discontinue use and consult a doctor if the condition worsens, symptoms persist for more than 7 days, or if redness or irritation develops. Additionally, pregnant or breastfeeding patients should consult a healthcare professional before use.

Drug Information (PDF)

This file contains official product information for Magsoothium Cbd Body, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)